QT Imaging Holdings (QTI)
NASDAQ:QTI
Top Page
QT Imaging Holdings
(NASDAQ:QTI)
Select Model
Select Model
Rating:53Neutral
Price Target:
$7.00
▲(17.65% Upside)
Action:ReiteratedDate:03/26/26
The score is held back primarily by weak financial performance (ongoing losses and cash burn despite improved equity) and limited valuation support (negative P/E, no dividend). These are partially offset by a constructive technical trend and positive corporate developments indicating accelerating commercialization and improved funding/liquidity.
Positive Factors
Commercial traction: record shipments and revenue growth
Substantial unit shipments and a meaningful revenue increase indicate tangible commercial adoption and improving go-to-market execution. A growing installed base supports recurring service, spare parts, and upgrade revenue streams, improving long-term scalability if adoption continues.
Negative Factors
Persistent negative operating and free cash flow
Sustained negative operating and free cash flow means core operations currently consume cash rather than fund growth. Losses converting to real cash outflows elevate refinancing and dilution risk and constrain the company's ability to invest in commercialization or R&D without additional financing.
Read all positive and negative factors
Positive Factors
Negative Factors
Commercial traction: record shipments and revenue growth
Substantial unit shipments and a meaningful revenue increase indicate tangible commercial adoption and improving go-to-market execution. A growing installed base supports recurring service, spare parts, and upgrade revenue streams, improving long-term scalability if adoption continues.
Read all positive factors
QT Imaging Holdings (QTI) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$79.60M
Dividend YieldN/A
Average Volume (3M)31.43K
Price to Earnings (P/E)―
Beta (1Y)0.12
Revenue Growth185.12%
EPS Growth21.22%
CountryUS
Employees10
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)-0.10
Shares Outstanding12,042,500
10 Day Avg. Volume22,708
30 Day Avg. Volume31,432
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)9.92
Price to Sales (P/S)3.38
P/FCF Ratio-7.04
Enterprise Value/Market Cap2.19
Enterprise Value/Revenue9.20
Enterprise Value/Gross Profit20.29
Enterprise Value/Ebitda-9.34
Forecast
1Y Price Target
$10.00Price Target Upside68.07% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.1
Revenue Forecast (FY)$38.75M
QT Imaging Holdings Business Overview & Revenue Model
Company Description
QT Imaging Holdings, Inc. engages in the manufacturing, research, and development of automated breast imaging system for producing high-resolution transmission ultrasound images. It offers QT Ultrasound Breast Scanner that provides reflection-mode...
How the Company Makes Money
null...
QT Imaging Holdings Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
27
Negative
Cash Flow
16
Very Negative
| Breakdown | Dec 2025 | Mar 2025 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 18.93M | 4.88M | 40.35K | 0.00 | 365.15K |
| Gross Profit | 8.58M | 2.64M | -94.63K | 0.00 | 104.58K |
| EBITDA | -4.44M | -4.27M | -5.07M | -2.26M | -4.27M |
| Net Income | -21.08M | -8.98M | -6.10M | -2.77M | -5.42M |
Balance Sheet | |||||
| Total Assets | 23.02M | 6.09M | 23.40M | 7.75M | 8.46M |
| Cash, Cash Equivalents and Short-Term Investments | 10.46M | 1.17M | 2.44K | 455.08K | 1.53M |
| Total Debt | 5.24M | 9.91M | 3.07M | 7.86M | 4.23M |
| Total Liabilities | 16.58M | 15.62M | 12.69M | 9.26M | 5.52M |
| Stockholders Equity | 6.45M | -9.54M | 10.71M | -1.51M | 2.94M |
Cash Flow | |||||
| Free Cash Flow | -9.08M | -10.12B | -1.94M | -3.88M | -2.72M |
| Operating Cash Flow | -8.96M | -10.03B | -1.94M | -3.86M | -2.70M |
| Investing Cash Flow | -124.00K | -87.79M | 19.92M | -22.60K | -18.37K |
| Financing Cash Flow | 18.35M | 11.13B | -18.05M | 2.78M | 3.67M |
QT Imaging Holdings Technical Analysis
Positive
5.95
Price Trends
5.98
Positive
5.99
Positive
6.11
Positive
Market Momentum
0.10
Positive
56.37
Neutral
40.05
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For QTI, the sentiment is Positive. The current price of 5.95 is below the 20-day moving average (MA) of 6.40, below the 50-day MA of 5.98, and below the 200-day MA of 6.11, indicating a bullish trend. The MACD of 0.10 indicates Positive momentum. The RSI at 56.37 is Neutral, neither overbought nor oversold. The STOCH value of 40.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for QTI.
QT Imaging Holdings Risk Analysis
QT Imaging Holdings disclosed 83 risk factors in its most recent earnings report. QT Imaging Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
QT Imaging Holdings Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
53 Neutral | $79.60M | -3.03 | 364.07% | ― | 185.12% | 21.22% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | $52.83M | -4.97 | 129.21% | ― | -15.02% | -11.06% | |
49 Neutral | $19.16M | -0.46 | -191.12% | ― | ― | -24.38% | |
47 Neutral | $20.72M | -2.58 | -221.04% | ― | -18.96% | 8.98% | |
45 Neutral | $57.44M | -1.67 | -82.79% | ― | 15.59% | 4.13% | |
42 Neutral | $50.06M | -1.22 | -28.16% | ― | -55.88% | 6.14% |
* Healthcare Sector Average
QTI
QT Imaging Holdings
6.61
5.04
321.02%
JSPR
Jasper Therapeutics
0.68
-2.89
-80.84%
LUNG
Pulmonx
1.36
-5.24
-79.39%
ALGS
Aligos Therapeutics
8.09
3.04
60.20%
MDAI
Spectral AI
1.66
0.48
40.68%
ICCM
Icecure Medical
0.30
-0.79
-72.39%
QT Imaging Holdings Corporate Events
Business Operations and StrategyExecutive/Board ChangesDelistings and Listing ChangesFinancial DisclosuresPrivate Placements and Financing
QT Imaging Posts Record Q4 Results and Revenue Growth
Positive
Mar 25, 2026
QT Imaging reported that for the fourth quarter and full year ended December 31, 2025, it shipped a record 40 Breast Acoustic CT scanners and generated $18.9 million in revenue, surpassing its outlook and marking 288% year-over-year growth, while ...
Business Operations and StrategyFinancial DisclosuresRegulatory Filings and Compliance
QT Imaging posts new investor presentation on technology
Neutral
Feb 25, 2026
On February 25, 2026, QT Imaging Holdings, Inc. reported that it had posted a new investor presentation on its website, offering supplemental product and operational information about the company and its breast imaging technology. The materials, f...
Business Operations and StrategyExecutive/Board ChangesDelistings and Listing ChangesFinancial DisclosuresPrivate Placements and Financing
QT Imaging Reports Record Q4 Revenue and Growth
Positive
Feb 18, 2026
On February 18, 2026, QT Imaging reported preliminary unaudited results showing record fourth-quarter 2025 revenue of $8.3 million, up 97% sequentially and 877% year-on-year, driven by shipments of 17 Breast Acoustic CT scanners, and full-year 202...
Financial DisclosuresRegulatory Filings and ComplianceStock Split
QT Imaging Files Audited 2024-2023 Financial Statements
Neutral
Feb 6, 2026
On November 3, 2025, QT Imaging Holdings, Inc. filed audited consolidated financial statements for the years ended December 31, 2024 and 2023, incorporating the effects of a reverse stock split completed on October 23, 2025. The audit, performed b...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.